Kegg medicus dgroup
| DG01468 | |
| DG番号 | DG01468 |
| 分類 | DGroup |
| 名称 | Dopamine D2-receptor agonist TYPE Target |
| ステム | - |
| 構造式 |  |
| メンバー | DG00452 Bromocriptine D03165 Bromocriptine (USAN/INN) D00780 Bromocriptine mesylate (USP); Bromocriptine mesilate (JP18) DG00453 Lisuride D08132 Lisuride (INN) D01462 Lisuride maleate (JAN) D00987 Cabergoline (JP18/USP/INN) DG00454 Quinagolide D07217 Quinagolide (INN/BAN) D08457 Quinagolide hydrochloride (BAN) D01348 Terguride (JAN/INN) DG00833 Dihydroergotamine D07837 Dihydroergotamine (INN) D02211 Dihydroergotamine mesylate (USP); Dihydroergotamine mesilate (JP18) D07838 Dihydroergotamine tartrate DG00834 Ergotamine D07906 Ergotamine (INN) D00679 Ergotamine tartrate (JP18/USP) DG00862 Ropinirole D08489 Ropinirole (USAN/INN) D00784 Ropinirole hydrochloride (JAN/USP) D05768 Rotigotine (JAN/USAN/INN) D04820 Lurasidone hydrochloride (JAN/USAN) DG01326 Talipexole D08558 Talipexole (INN) D01505 Talipexole hydrochloride (JAN) DG01319 Lergotrile D04693 Lergotrile (USAN/INN) D04694 Lergotrile mesylate (USAN) D05677 Quinelorane hydrochloride (USAN) D05832 Sibenadet hydrochloride (USAN) |
| 上位グループ | Neuropsychiatric agent DG01472 Dopamine agonist |
| 注釈1 | - |
| 注釈2 | - |